NICOLE CARSON: Open Payments
NPI 1023086089 · BUCKINGHAM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,095 in 50 payments from 16 companies in 2025. Trend: 2023 $1,139 · 2024 $1,024 · 2025 $1,095
Food & beverage: $1,078Education: $17
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $206 |
| Vanda Pharmaceuticals Inc. | 7 | $188 |
| Neurocrine BioSciences, Inc. | 6 | $144 |
| Teva Pharmaceuticals USA, Inc. | 5 | $95 |
| Lundbeck LLC | 4 | $79 |
| Tris Pharma Inc | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Almatica Pharma LLC | 2 | $36 |
Products named: VRAYLAR, HETLIOZ, INGREZZA, AUSTEDO XR, REXULTI, Dyanavel XR, ABILIFY ASIMTUFII, COBENFY.
Industry payments across PA — which companies pay providers there.
